Status:
COMPLETED
Multimodal Image Processing Software to Guide Cardiac Ablation Therapy
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Ventricular Arrhythmias
Persistent Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
MIGAT will develop and transfer software tools to assist ablation therapy of cardiac arrhythmias. The scientific background and objectives of MIGAT differ between atrial and ventricular arrhythmias, b...
Detailed Description
Cardiac electrical disorders are a major cause of human mortality and morbidity worldwide. Catheter ablation therapy has become part of international recommendations for the management of both atrial ...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Body weight \< 140 kg
- Indicated ablation for ventricular tachycardia or persistent atrial fibrillation
Exclusion
- Severe renal insufficiency defined by creatinine clearance \< 30 mL/min
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 21 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02275104
Start Date
September 1 2014
End Date
July 21 2016
Last Update
February 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital cardiologique du Haut-Lévêque
Pessac, France, 33604